Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia

doi:10.1016/j.ctrv.2016.05.002

Review

. 2016 Jun:47:22-31.

doi: 10.1016/j.ctrv.2016.05.002. Epub 2016 May 10.

Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia

Wei Shen Tan¹, Simon Rodney², Benjamin Lamb³, Mark Feneley³, John Kelly²

Affiliations

¹ Division of Surgery and Interventional Science, University College London, 74 Huntley Street, London WC1E 6AU, UK; Department of Urology, University College London Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK. Electronic address: wei.tan@ucl.ac.uk.
² Division of Surgery and Interventional Science, University College London, 74 Huntley Street, London WC1E 6AU, UK; Department of Urology, University College London Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK.
³ Department of Urology, University College London Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK.

PMID: 27231966
DOI: 10.1016/j.ctrv.2016.05.002

Review

Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia

Wei Shen Tan et al. Cancer Treat Rev. 2016 Jun.

. 2016 Jun:47:22-31.

doi: 10.1016/j.ctrv.2016.05.002. Epub 2016 May 10.

Authors

Wei Shen Tan¹, Simon Rodney², Benjamin Lamb³, Mark Feneley³, John Kelly²

Affiliations

¹ Division of Surgery and Interventional Science, University College London, 74 Huntley Street, London WC1E 6AU, UK; Department of Urology, University College London Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK. Electronic address: wei.tan@ucl.ac.uk.
² Division of Surgery and Interventional Science, University College London, 74 Huntley Street, London WC1E 6AU, UK; Department of Urology, University College London Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK.
³ Department of Urology, University College London Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK.

PMID: 27231966
DOI: 10.1016/j.ctrv.2016.05.002

Abstract

Bladder cancer is the 8th most common cancer with 74,000 new cases in the United States in 2015. Non-muscle invasive bladder cancer (NMIBC) accounts for 75% of all bladder cancer cases. Transurethral resection and intravesical treatments remain the main treatment modality. Up to 31-78% of cases recur, hence the need for intensive treatment and surveillance protocols which makes bladder cancer one of the most expensive cancers to manage. The purpose of this review is to compare contemporary guidelines from Europe, (European Association of Urology), the United States (National Comprehensive Cancer Network), the United Kingdom (National Institute for Health and Care Excellence), Japan (Japanese Urological Association) and the International Consultation on Bladder Cancer (ICUD). We compare and contrast the different guidelines and the evidence on which their recommendations are based.

Keywords: Bladder cancer; Consensus guidelines; Non-muscle invasive bladder cancer; Recommendations; Review.

PubMed Disclaimer

Comment in

Re: Management of Nonmuscle Invasive Bladder Cancer: A Comprehensive Analysis of Guidelines from the Unites States, Europe, and Asia.
de Vere White R. de Vere White R. Eur Urol. 2017 Apr;71(4):688. doi: 10.1016/j.eururo.2016.12.017. Epub 2017 Jan 7. Eur Urol. 2017. PMID: 28073601 No abstract available.

Cited by

DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells.
Tan WS, Feber A, Dong L, Sarpong R, Rezaee S, Rodney S, Khetrapal P, de Winter P, Ocampo F, Jalil R, Williams NR, Brew-Graves C, Kelly JD. Tan WS, et al. BMC Cancer. 2017 Nov 15;17(1):767. doi: 10.1186/s12885-017-3758-7. BMC Cancer. 2017. PMID: 29141603 Free PMC article.
Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends.
Shalata AT, Shehata M, Van Bogaert E, Ali KM, Alksas A, Mahmoud A, El-Gendy EM, Mohamed MA, Giridharan GA, Contractor S, El-Baz A. Shalata AT, et al. Cancers (Basel). 2022 Oct 14;14(20):5019. doi: 10.3390/cancers14205019. Cancers (Basel). 2022. PMID: 36291803 Free PMC article. Review.
UroMark-a urinary biomarker assay for the detection of bladder cancer.
Feber A, Dhami P, Dong L, de Winter P, Tan WS, Martínez-Fernández M, Paul DS, Hynes-Allen A, Rezaee S, Gurung P, Rodney S, Mehmood A, Villacampa F, de la Rosa F, Jameson C, Cheng KK, Zeegers MP, Bryan RT, James ND, Paramio JM, Freeman A, Beck S, Kelly JD. Feber A, et al. Clin Epigenetics. 2017 Jan 31;9:8. doi: 10.1186/s13148-016-0303-5. eCollection 2017. Clin Epigenetics. 2017. PMID: 28163793 Free PMC article.
KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.
Zheng P, Wu K, Gao Z, Li H, Li W, Wang X, Shi Z, Xiao F, Wang K, Li Z, Han Q. Zheng P, et al. Int J Mol Med. 2021 Jun;47(6):99. doi: 10.3892/ijmm.2021.4932. Epub 2021 Apr 13. Int J Mol Med. 2021. Retraction in: Int J Mol Med. 2023 Jul;52(1):62. doi: 10.3892/ijmm.2023.5265 PMID: 33846765 Free PMC article. Retracted.
Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer.
Guo H, Li F, Xu W, Chen J, Hou Y, Wang C, Ding J, Chen X. Guo H, et al. Adv Sci (Weinh). 2018 Mar 27;5(6):1800004. doi: 10.1002/advs.201800004. eCollection 2018 Jun. Adv Sci (Weinh). 2018. PMID: 29938183 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia

Affiliations

Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia

Authors

Affiliations

Abstract

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical